34.000
−1,45%
2026-10-19
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +22.7% | -4.1% | 2 / 3 | +33.3% | -1.86 pp | -0.47 pp | +10.7% | 0.00 | 18.26 | 98,2 | +33,3% | 5,4 | +22,7% | 18.26 | 27.28 | −33,1% |
| Pts | 4 | 0 | 8 | 12 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 34.000 (close price on 2026-10-19)EPS (TTM): 1.862
Financial charts
1.Revenue & growth
VND bn98,2Q2/26
1.Revenue & growth
VND bn98,2Q2/26
2.Profit & growth
VND bn5,38Q2/26
3.Profit mix (Penman)
VND bn21,1Q2/26
4.Margins & cost structure
%11.4%Q2/26
5.Returns & cash cycle
% · days15.1%Q2/26
6.Earnings quality & cash
VND bn8,56Q2/26
7.Asset structure
VND bn270Q2/26
8.Funding & debt health
VND bn · times270Q2/26
9.Revenue backlog
VND bn2,49Q2/26
10.Valuation
times · %18,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %598Q2/26
Adjusted EPS growth, latest quarter
22.7%
Average adjusted EPS growth, 3 quarters
-4.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26